drugset / Trial / NCT00276692
Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma
Open-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy, such as irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well irinotecan works in treating patients with newly diagnosed Ewing's sarcoma.
Timeline
- Start
- 2003-08
- Primary completion
- 2008-09
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | — | Intravenous |